MANZO PHARMACEUTICALS, INC.

All News Manzo Pharmaceuticals, Inc.

Equities

MNZO

US56510D1063

Market Closed - OTC Markets Other stock markets 19:26:21 18/03/2024 GMT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

05-21	Manzo Pharmaceuticals, Inc. announced that it expects to receive $0.0005 million in funding	CI
2015	Manzo Pharmaceuticals Inc. Announces New Product Somnaid Release	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Manzo Pharmaceuticals, Inc. announced that it expects to receive $0.0005 million in funding	05-20	CI
Manzo Pharmaceuticals Inc. Announces New Product Somnaid Release	08/06/15	CI
Manzo Pharmaceuticals Announces Positive Results from Laboratory Study of Lacto-Freedom Probiotic	03/02/15	CI
Manzo Pharmaceuticals Gets Confirmation of Lacto-Freedom Probiotic is Dietary Supplement and Will Not Need FDA Approval	07/10/14	CI
Fortune Oil & Gas, Inc. has Changed its Ticker to FOGCD from FOGC	17/09/14	CI
Fortune Oil & Gas, Inc. has Changed its Name to Manzo Pharmaceuticals, Inc	17/09/14	CI
Fortune Oil & Gas Appoints Kenneth Manzo as CEO and Chairman	11/06/14	CI
Fortune Oil & Gas, Inc. acquired Manzo Pharmaceuticals, LLC.	11/06/14	CI
Fortune Oil & Gas, Inc. Agrees as Kabe Exploration Inc.'s Operator of Kansas Mississippian Lime Acreage for Oil Development	16/01/13	CI
Kabe Exploration Inc. Announces Intention to Hire Fortune Oil & Gas, Inc. as the Operator for Oil and Gas Assets on Turn-Key Basis	13/12/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
MNZO Stock
News Manzo Pharmaceuticals, Inc.

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer